Ryusuke Suzuki
, SHEM Co., Ltd, JapanTitle : Clinical Evaluation after Introduction of Stem Cell Supernatant Biocell Shot 65 by Electroporation
Abstract
Objectives: The objective
of this study is clinical evaluation after introduction of stem cell
supernatant Biocell Shot 65 by electroporation.
Background: There is a
clinical report of psoriasis treatment by umbilical cord blood-derived stem
cells, in which there was a beneficial result. We suppose that the supernatant
has the esthetic effect of improving skin condition, thus, we planned to make a
clinical evaluation. However, it is difficult to set judgement criteria, and
human judgement tends to be subjective. Therefore, in this study, as a new
clinical evaluator, we used an AI skin diagnostic device with learning
function.
Methods: Stem cell culture
supernatant biocell Shot 65 was used as an introduction solution. After it was
applied to the full faces of four patients, electroporation with BeBe pinocchio
DM-5 SUPER DX Plus promoted infiltration deep in the keratinized layer. The
patients were all healthy women in their forties. This procedure was performed
every two weeks for three months. Wrinkles, fine lines around eyes, stains,
pores, and 4V, which is considered as one diagnostic criteria, were evaluated
at baseline and after each procedure with the skin diagnostic device
HiMirror-Professional.
Results: In all four
patients, 4V did not change remarkably. The mean values of all the patients
were plotted and compared before and after each procedure, there was a trend
toward improvements after the fifth procedure.
Conclusion: In addition to
application of supernatant culture to the skin, introduction of the solution to
the skin by electroporation might improve stains, wrinkles, and pores. Our
evaluation was performed with a facial diagnostic device during three months
after the start of the procedure.
Biography
Ryusuke Suzuki has completed his
PHD at the age of 28 years from Kitasato University, USA. He was the visiting
researcher of R&D Center for Artificial Skin, School of Allied Health
Sciences, Kitasato University, Japan. He has over 10 publications. He is the
president of SHEM Co., Ltd. He is an advisor to more than 10 pharmaceutical,
cosmetics and health equipment manufacturers, helping to develop new products.